Is Gland Pharma Ltd (GLAND) Halal and Shariah Compliant?
Current Price
Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets. We operate primarily under a business to business (B2B) model and have an excellent track record in the development, manufacturing and marketing of complex injectabl
- Company has reduced debt.
- Company is almost debt free.
- The company has delivered a poor sales growth of 5.62% over past five years.
- Company has a low return on equity of 12.3% over last 3 years.
Shariah Compliance Analysis of Gland Pharma Ltd
When navigating the Indian stock market, ethical investors constantly seek to align their portfolios with Islamic finance principles. A frequent question we receive is whether Gland Pharma Ltd (GLAND) is Halal and Shariah compliant. To accurately determine the Shariah compliance status of Gland Pharma Ltd, we must conduct a comprehensive quantitative and qualitative analysis of both its core business operations and its underlying financial health.
Business Sector Screening for GLAND
The very first and most critical step in Halal stock screening is ensuring that the primary business activities of Gland Pharma Ltd do not violate Islamic law. Companies heavily involved in prohibited (Haraam) sectors like conventional banking, alcohol, gambling, and adult entertainment are strictly excluded. If Gland Pharma Ltd derives its core revenue from permissible (Halal) activities, it successfully advances to the financial ratio analysis phase.
Financial Ratio Analysis
Even if a prominent company like Gland Pharma Ltd operates entirely within a Halal sector, it must still pass strict financial screens to guarantee its corporate practices align with Shariah principles.
- Debt to Total Assets: The interest-bearing debt of Gland Pharma Ltd must not exceed the universally accepted threshold (typically 30% or 33%).
- Illiquid to Total Assets: Gland Pharma Ltd must maintain a sufficient percentage of tangible, illiquid assets in its portfolio.
- Impermissible Income: Any incidental non-compliant revenue (like interest) must strictly remain below 5% of total gross revenue.
Dividend Purification for Gland Pharma Ltd
If Gland Pharma Ltd (GLAND) passes both the sector screens and strict financial tests, it is classified as a Halal stock. However, any incidental impermissible income earned by the company must be cleansed. Investors holding GLAND are required to calculate their dividend purification ratio and donate that exact portion to charity, with no expectation of spiritual reward (Sawab), purifying their Halal earnings.
By utilizing our advanced Halal stock screener platform, you can effortlessly track the live Shariah compliance status of Gland Pharma Ltd (GLAND), view historical compliance trends, and access precise dividend purification calculations. Make informed, ethical investment decisions with confidence.
⚠️ Disclaimer & Research Notice: This analysis is for informational and reference purposes only. It is not financial advice, and we are not responsible for any financial losses or damages incurred. Always do your own research (DYOR) and consult with a qualified Shariah advisor or financial planner before making any investment decisions.